Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
Authors
Discussion
Loading...
Member takes
Implication
Expert consensus reveals standardized diagnostic and treatment criteria in classic hairy cell leukemia, highlighting the need for uniform definitions of disease response and relapse.
Key Points
- Establish international consensus guidelines for the diagnosis, response evaluation, and management of classic hairy cell leukemia to optimize patient care and standardize clinical trials.
- Convened an international expert conference organized by the Hairy Cell Leukemia Foundation to establish consensus definitions and clinical structures.
- Evaluated current management paradigms across initial therapy, relapsed disease, infection prophylaxis, and the assessment of minimal residual disease.
- Formulated reproducible, standardized definitions for clinical response, relapse, and minimal residual disease to permit accurate comparisons across diverse clinical trials.
- Identified infection prevention, immunosuppression monitoring, and health-related quality of life for long-term survivors as critical priorities in clinical management.
- Established recommendations prioritizing clinical trial enrollment for both front-line treatment and relapsed disease management.
Cite This Study
Grever et al. (2016) studied this question.